기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
사람 혈청내 B형과 C형 간염바이러스에 대한 항체분포
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • 사람 혈청내 B형과 C형 간염바이러스에 대한 항체분포
  • Distribution of Antibodies Against Hepatitis B virus and Hepatitis C virus in Human Sera
저자명
최진섭,성인화,Choi. Jin-Sub,Seong. In-Wha
간행물명
대한바이러스학회지
권/호정보
1997년|27권 2호|pp.129-135 (7 pages)
발행정보
대한바이러스학회
파일정보
정기간행물|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

Serum samples from 123 males and 123 females collected by age in 1996 were analyzed for antibodies against surface antigen of Hepatitis B virus and C22-3, C200 antigens of Hepatitis C virus. Sera from the children under the age of 10 showed 30% seropositivity to the surface antigen of Hepatitis B virus, 33.3% in $10{sim}19$ year group, 20% in $20{sim}29$ year group, 17.6% in $30{sim}39$ year group, 3.3% in $40{sim}49$ year group, 5.9% in $50{sim}59$ year group, 8,3% in $60{sim}69$ year group, 2.9% in $70{sim}79$ year group, but antibody could not found in $80{sim}86$ year group. 12 out of 123 male sera were positive, 19 out of 123 female sera were positive and overall rate of positivity of antibody against surface antigen of Hepatitis B virus was 12.6%. Serum samples from peoples under the age of 30 had not antibody against C22-3, C200 antigens of Hepatitis C virus. The positivity rate was 2.9% in $30{sim}39$ year group. 5 out of 30 sera from $40{sim}49$ year age group were positive, and 3 positive sera showed extremely high titer (1:524,288) but the titers of two remaining sera were 1:32, 1:8,192 respectively. 5.9% was positive in $50{sim}59$ year group, 8.3% in $60{sim}69$ year group, 11.8% in $70{sim}79$ year group but all negative in $80{sim}86$ year group 6 out of 123 male sera were positive (4.9%), 9 out of 123 female sera were positive (7.3%). Overall rate of positivity of antibody against C22-3, C200 antigen of Hepatitis C virus was 6.1 %. None out of 246 sera had both antibodies against Hepatitis B virus and Hepatitis C virus.